Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial

被引：0
|
作者：
Piccini, Jonathan P. [1 ]
Stevens, Susanna [1 ]
Lokhnygina, Yuliya [1 ]
Patel, Manesh [1 ]
Singer, Daniel [2 ]
Halperin, Jonathan [3 ]
Hankey, Graeme [4 ]
Hacke, Werner [5 ]
Becker, Richard [1 ]
Nessel, Christopher [6 ]
Mahaffey, Kenneth [1 ]
Fox, Keith [7 ]
Califf, Robert [1 ]
Breithardt, Gunter [8 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Rsch Inst, Durham, NC USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Mt Sinai Med Ctr, New York, NY 10029 USA
[4] Royal Perth Hosp, Perth, WA 6001, Australia
[5] Heidelberg Univ, Heidelberg, Germany
[6] Johnson & Johnson Pharmaceut Rsch & Dev, Raritan, NJ USA
[7] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[8] Hosp Univ Munster, Munster, Germany
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Atrial fibrillation; Ablation; Anticoagulaion;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19281
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial
    Piccini, Jonathan P.
    Garg, Jyotsna
    Patel, Manesh R.
    Lokhnygina, Yuliya
    Goodman, Shaun G.
    Becker, Richard C.
    Berkowitz, Scott D.
    Breithardt, Guenter
    Hacke, Werner
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Singer, Daniel E.
    Califf, Robert M.
    Fox, Keith A. A.
    EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1873 - 1880
  • [32] The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
    Koroleva, Lyubov Yu.
    Kolesnichenko, Irina V.
    Nosov, Vladimir P.
    Zlobin, Maxim V.
    Abelevich, Dmitry I.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (05) : 553 - 557
  • [33] Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
    Breithardt, Gunter
    Baumgartner, Helmut
    Berkowitz, Scott D.
    Hellkamp, Anne S.
    Piccini, Jonathan P.
    Stevens, Susanna R.
    Lokhnygina, Yuliya
    Patel, Manesh R.
    Halperin, Jonathan L.
    Singer, Daniel E.
    Hankey, Graeme J.
    Hacke, Werner
    Becker, Richard C.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Fox, Keith A. A.
    Califf, Robert M.
    EUROPEAN HEART JOURNAL, 2014, 35 (47) : 3377 - 3385
  • [34] Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iekushi, Kazuma
    Yamanaka, Satoshi
    Tajiri, Masahiro
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (02): : 379 - 383
  • [35] IMPACT OF RENAL FUNCTION ON CLINICAL OUTCOMES AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH WARFARIN OR RIVAROXABAN
    Weir, M. R.
    Haskell, L.
    Berger, J. S.
    Ashton, V
    Laliberte, F.
    Crivera, C.
    Brown, K.
    Lefebvre, P.
    Schein, J. R.
    VALUE IN HEALTH, 2017, 20 (05) : A261 - A262
  • [36] Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Cavaliere, Mary
    Iekushi, Kazuma
    Yamanaka, Satoshi
    JOURNAL OF CARDIOLOGY, 2016, 68 (5-6) : 523 - 528
  • [37] Stroke Prevention Using the Oral Direct Factor Xa Inhibitor Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation (ROCKET AF)
    Patel, Manesh R.
    CIRCULATION, 2010, 122 (21) : 2217 - 2217
  • [38] Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF
    Uchiyama, Shinichiro
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iekushi, Kazuma
    Yamanaka, Satoshi
    Tajiri, Masahiro
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (05): : 1142 - 1147
  • [39] Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation for the Secondary Prevention of Stroke: A Subgroup Analysis of J-ROCKET AF
    Tanahashi, Norio
    Hori, Masatsugu
    Matsumoto, Masayasu
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iwamoto, Kazuya
    Tajiri, Masahiro
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (08): : 1317 - 1325
  • [40] Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial
    Lip, Gregory Y.
    Al-Saady, Naab
    Jin, James
    Sun, Ming
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    Zamoryakhin, Dmitry
    CIRCULATION, 2016, 134
12345